EUVIMEDEUVIMED entdecken
Crossref

RP-HPLC Analytical Method Development and Validation for the Simultaneous Estimation of Bempedoic Acid and Ezetimibe in Bulk and Tablet Dosage Form

Sreenivasa Charan Archakam, Keerthisikha Palur, M Jyothika, P Chaitanya

International Journal of Drug Delivery Technology · 11.05.2026 · 16 (26s)

DOI: 10.25258/ijddt.16.26s.56 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.05.2026. Verfasst von Sreenivasa Charan Archakam und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Validated analytical methods are the backbone of pharmaceutical quality assurance, ensuring that drug products meet safety and efficacy standards. The present study aimed to develop and validate a simple, accurate, precise, and costeffective reverse-phase high-performance liquid chromatographic (RP-HPLC) method for the simultaneous quantification of Bempedoic acid and Ezetimibe in bulk powder and tablet dosage form, suitable for routine pharmaceutical quality control. Chromatographic separation was accomplished using a Kromosil C18 column (150 × 4.6 mm, 3.0 µm particle size) with a mobile phase of 0.01 N potassium dihydrogen phosphate (KH2PO4) buffer and methanol (70:30 v/v), pumped at a flow rate of 0.9 mL/min. The column temperature was maintained at 30°C, with UV detection at 260 nm and an injection volume of 10 µL. The method was validated in accordance with ICH Q2(R1) guidelines for system suitability, linearity, precision, accuracy, robustness, limit of detection (LOD), limit of quantification (LOQ), specificity, and drug assay. Retention times were 2.780 min for Bempedoic acid and 2.123 min for Ezetimibe. Excellent linearity was observed with regression equations y = 28262x + 4418.6 (R² = 0.9999) for Bempedoic acid and y = 28796x + 190.13 (R² = 0.9999) for Ezetimibe. System precision %RSD values were 0.6% and 1.3% for Bempedoic acid and Ezetimibe, respectively. Mean percentage recoveries were 99.87% and 100.12%, respectively. LOD values were 0.10 and 0.01 µg/mL, and LOQ values were 0.35 and 0.03 µg/mL for Bempedoic acid and Ezetimibe, respectively. The developed RP-HPLC method was found to be simple, rapid, specific, and reliable for the simultaneous estimation of Bempedoic acid and Ezetimibe in bulk and tablet dosage forms, with compliance to ICH guidelines confirming its suitability for industrial quality control applications.

Zitieren

APA

Archakam, S. C., Palur, K., Jyothika, M., & Chaitanya, P. (2026). RP-HPLC Analytical Method Development and Validation for the Simultaneous Estimation of Bempedoic Acid and Ezetimibe in Bulk and Tablet Dosage Form. International Journal of Drug Delivery Technology, 16(26s). https://doi.org/10.25258/ijddt.16.26s.56

Vancouver

Archakam SC, Palur K, Jyothika M, Chaitanya P. RP-HPLC Analytical Method Development and Validation for the Simultaneous Estimation of Bempedoic Acid and Ezetimibe in Bulk and Tablet Dosage Form. International Journal of Drug Delivery Technology. 2026;16(26s). doi:10.25258/ijddt.16.26s.56

BibTeX
@article{Archakam2026,
  author = {Archakam, Sreenivasa Charan and Palur, Keerthisikha and Jyothika, M and Chaitanya, P},
  title = {RP-HPLC Analytical Method Development and Validation for the Simultaneous Estimation of Bempedoic Acid and Ezetimibe in Bulk and Tablet Dosage Form},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {26s},
  doi = {10.25258/ijddt.16.26s.56}
}
Kostenlos starten →